GE expands Biosense Webster deal for ultrasound tech:
This article was originally published in Clinica
Executive Summary
GE Healthcare and Biosense Webster have extended a long-standing strategic partnership, with the aim of developing real-time ultrasound imaging technology for use in electrophysiology procedures. The partnership, of which financials details were not revealed, will see GE combine its ultrasound imaging capabilities with EP catheter technology belonging to Diamond Bar, California-based Biosense Webster. GE claims the two companies are to co-develop imaging solutions specifically for intracardiac therapies. The companies had previously built an alliance in order to integrate GE's CardioLab IT system for electrophysiology recording with Biosense Webster's Carto mapping system.
You may also be interested in...
P&G's $8M Benzene Settlement Preliminarily Approved By Ohio Federal Court
The Cincinnati, OH-based firm will pay $8m to recompense Unites States residents who purchased aerosol personal-care products potentially contaminated with benzene over a roughly six-year period.
Food For Thought On US FDA Reforms
An independent review of the US FDA’s food regulatory programs could renew a debate over splitting FDA into two agencies. That could be a distraction for the agency in the coming year – but it could also help keep the medical product review groups out of the political hot seat.
FDA’s Win-Win: More Comprehensive IND Safety Reports With Minimal Effort Due To Harmonization
New proposed rule calls for replacing US FDA’s current annual reporting requirements for INDs with a safety update report that is consistent the format and content of the development safety update report (DSUR) supported by the International Council of Harmonisiation.